Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 2Active not recruiting 2Unknown 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 6Lung Neoplasms 3Recurrence 2Neoplasms 2Melanoma 2Glioblastoma 2Vulvar Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Carcinoma, Anaplastic 1Skin Neoplasms 1Rectal Neoplasms 1Penile Neoplasms 1Mesothelioma, Malignant 1Head and Neck Neoplasms 1Gliosarcoma 1Glioma 1Ependymoma 1Disease Progression 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Renal Cell 1Carcinoma, Merkel Cell 1Carcinoma 1Advanced Squamous Non-Small Cell Lung Cancer 1Adenocarcinoma 1

Interventions

pembrolizumab 1decitabine and cedazuridine drug combination 1cemiplimab 1Specimen Handling 1Nivolumab 1Magnetic Resonance Spectroscopy 1Hematologic Tests 1Etoposide 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Carcinoma, Merkel Cell × cemiplimab × Clear all
NCT07387198 2026-04-17

NeoMatryx

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

Phase 2 Not yet recruiting
135 enrolled
Dermatologic

Skin Neoplasms, Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡